LICENSE AGREEMENT (the “Agreement”)License Agreement • November 21st, 2011 • Mabcure Inc. • In vitro & in vivo diagnostic substances • New York
THIS AGREEMENT, is entered into this 10th day of November, 2011, by and between MabCure Inc., a Nevada corporation with a principal place of business at 760 Parkside Avenue, Brooklyn, NY (“MabCure”), and Biotech Investment Corp., a Nevada corporation with a principal place of business at Sharabi Street No. 6, Tel Aviv, 65147 Israel (“NewCo”).
